Home/Filings/4/0001144204-17-001879
4//SEC Filing

Nuo Therapeutics, Inc. 4

Accession 0001144204-17-001879

$AURXCIK 0001091596operating

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 8:17 PM ET

Size

6.1 KB

Accession

0001144204-17-001879

Insider Transaction Report

Form 4
Period: 2017-01-09
Transactions
  • Award

    Option to purchase Common Stock

    2017-01-09+40,00040,000 total
    Exercise: $1.00Exp: 2026-07-01Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]The grant of these options was approved by the issuer's board of directors on July 1, 2016, subject to stockholder approval of the 2016 Omnibus Incentive Compensation Plan under which the options were granted. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on November 25, 2016. The stockholder approval became effective on January 9, 2017.
  • [F2]Of these options, 15,000 vested immediately, and 25,000 vested on 1/1/17.

Issuer

Nuo Therapeutics, Inc.

CIK 0001091596

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001091596

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 8:17 PM ET
Size
6.1 KB